Efficacy and tolerability assessment of a topical formulation containing copper sulfate and Hypericum perforatum on patients with herpes skin lesions: A comparative, randomized controlled trial

Journal of Drugs in Dermatology

Volumn 11, Issue 2, 2012, Pages 209-215

  Clewell, Amy ^a   Barnes, Matt ^a   Endres, John R ^a   Ahmed, Mansoor ^b   Ghambeer, Daljit K S ^c  

^a AIBMR Life Sciences Inc   (United States)

^b Sci chem International Pty Ltd   (Australia)

^c Apothecaries Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; COPPER SULFATE; DYNAMICLEAR; HYPERICUM PERFORATUM EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BURNING SENSATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HYPERICUM PERFORATUM; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ACYCLOVIR; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; COPPER SULFATE; ERYTHEMA; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; HYPERICUM; MALE; MIDDLE AGED; PLANT EXTRACTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856944848     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chayavichitsilp P, Buckwalter JV, Krakowski AC, Friedlander SF. Herpes simplex. Pediatr Rev. 2009;30(4):119-129; quiz 30.
2. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. 2007;57(5):737-763; quiz 64-66.
3. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet. 2001;12;357(9267):1513-1518.
4. Simmons A. Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infect Dis. 2002;186(suppl 1):71S-77S.
5. WHO. Prevention and control of herpesvirus diseases. Part 1. Clinical and laboratory diagnosis and chemotherapy. A WHO meeting. Bull World Health Organ. 1985;63(2):185-201 contd.
6. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis. 2002;185(1):45-52. (Pubitemid 34043015)
7. Sagripanti JL, Routson LB, Bonifacino AC, Lytle CD. Mechanism of copper-mediated inactivation of herpes simplex virus. Antimicrob Agents Chemother. 1997;41(4):812-817. (Pubitemid 27150537)
8. Chilukuri S, Rosen T. Management of acyclovir-resistant herpes simplex virus. Dermatol Clin. 2003;21(2):311-320. (Pubitemid 36529765)
9. Mundinger T, Efferth T. Herpes simplex virus: Drug resistance and new treatment options using natural products (review). Molecular Medicine Reports. 2008;1:611-616.
10. Barton SE, Munday PE, Kinghorn GR, et al. Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): Double blind, placebo controlled, multicentre study. Genitourin Med. 1986;62(4):247-250. (Pubitemid 16039487)
11. Shaw M, King M, Best JM, Banatvala JE, Gibson JR, Klaber MR. Failure of acyclovir cream in treatment of recurrent herpes labialis. Br Med J (Clin Res Ed). 1985;291(6487):7-9. (Pubitemid 15068791)
12. Cheng YB, Liao TC, Lo YW, et al. Nortriterpene lactones from the fruits of Schisandra arisanensis. J Nat Prod. 2010;73(7):1228-1233.
13. Eo SK, Kim YS, Lee CK, Han SS. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. Journal of Ethnopharmacology. 1999;68(1-3):129-136.
14. Reuter J, Wolfle U, Weckesser S, Schempp C. Which plant for which skin disease? Part 1: Atopic dermatitis, psoriasis, acne, condyloma and herpes simplex. J Dtsch Dermatol Ges. 2010;8(10):788-796.
15. Lai F, Sinico C, De Logu A, Zaru M, Muller RH, Fadda AM. SLN as a topical delivery system for Artemisia arborescens essential oil: In vitro antiviral activity and skin permeation study. Int J Nanomedicine. 2007;2(3):419-425. (Pubitemid 350047785)
16. Patwardhan B, Gautam M. Botanical immunodrugs: Scope and opportunities. Drug Discov Today. 2005;10(7):495-502. (Pubitemid 40487492)
17. Jaeger Greer MR, Cates RG, Johnson FB, Lamnaouer D, Ohai L. Activity of acetone and methanol extracts from thirty-one medicinal plant species against herpes simplex virus types 1 and 2. Pharm Biol. 2010;48(9):1031-1037.
18. McQuestion M. Evidence-based skin care management in radiation therapy. Semin Oncol Nurs. 2006;22(3):163-173. (Pubitemid 44163101)
19. Birt DF, Widrlechner MP, Hammer KD, et al. Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents. Pharm Biol. 2009;47(8):774-782.
20. Galeotti N, Vivoli E, Bilia AR, Vincieri FF, Ghelardini C. St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity. Biochem Pharmacol. 2010;79(9):1327-1336.
21. Shishkov S, Varadinova T, Panteva M, Bontchev P. Effect of Complexes of Zinc, Cobalt and Copper With D-Aminosugars on the Replication of Herpes Simplex Virus Type 1 (HSV-1). Met Based Drugs. 1997;4(1):35-38. (Pubitemid 27234691)
22. Panteva M, Varadinova T, Turel I. Effect of Copper Acyclovir Complexes on Herpes Simplex Virus Type 1 and Type 2 (HSV-1, HSV-2) Infection in Cultured Cells. Met Based Drugs. 1998;5(1):19-23. (Pubitemid 28185312)
23. Lewis RJ, Tatken RL, eds. Registry of Toxic Effects of Chemical Substances, Vol. 1. Vol 2. Rockville, MD: Superintendent of Documents; 1980. p. 383.
24. Lopez BS, Yamamoto M, Utsumi K, Aratsu C, Sakagami H. A clinical pilot study of lignin - ascorbic acid combination treatment of herpes simplex virus. In Vivo. 2009;23(6):1011-1016.